Liquid biopsy using extracellular vesicle–derived DNA in lung adenocarcinoma

Blood liquid biopsy has emerged as a way of overcoming the clinical limitations of repeat biopsy by testing for the presence of acquired resistance mutations to therapeutic agents. Despite its merits of repeatability and non-invasiveness, this method is currently only used as a supplemental test due...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Pathol Transl Med
Egile Nagusiak: Kim, In Ae, Hur, Jae Young, Kim, Hee Joung, Lee, Seung Eun, Kim, Wan Seop, Lee, Kye Young
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Society of Pathologists and the Korean Society for Cytopathology 2020
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7674759/
https://ncbi.nlm.nih.gov/pubmed/33027851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2020.08.13
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak